Literature DB >> 20930010

Bronchoalveolar lavage in children with cystic fibrosis: how many lobes should be sampled?

F J Gilchrist1, S Salamat, S Clayton, J Peach, J Alexander, W Lenney.   

Abstract

BACKGROUND: The European Respiratory Society guidance on bronchoalveolar lavage (BAL) in children was published in 2000. It recommended taking one BAL specimen from the most affected lobe or from the right middle lobe in diffuse disease. In 2007, the European Respiratory Society modified the recommendations for children with cystic fibrosis (CF), suggesting two BAL specimens (right middle lobe and the lingula or the most affected lobe).
OBJECTIVE: To determine if BAL samples from one or two lobes give the full picture of lower airway infection in children with CF. DESIGN, SETTING AND PATIENTS: A retrospective review of all paediatric patients with CF who underwent flexible bronchoscopy between May 2007 and May 2009 was undertaken. MAIN OUTCOME MEASURES: As BAL specimens from all six lobes were collected, the BAL results were reviewed to identify if positive cultures would have been missed if only one lobe (right middle or most affected) or two lobes (right middle plus the lingula or most affected) had been sampled.
RESULTS: The results of 39 bronchoscopic procedures in 31 children were reviewed. The BAL samples were taken from 6 lobes in all 39 procedures. Had only one lobe been used, 26 positive cultures (14 organisms) would have been missed in 11 patients. Had two lobes been used, 12 positive cultures (8 organisms) would have been missed in 7 patients.
CONCLUSION: A single-lobe BAL is insufficient in assessing patients with CF for lower airway infection. Even when BAL specimens are taken from two lobes, a number of infections may be missed.

Entities:  

Mesh:

Year:  2010        PMID: 20930010     DOI: 10.1136/adc.2009.177618

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  14 in total

1.  Spatial distribution of microbial communities in the cystic fibrosis lung.

Authors:  Dana Willner; Matthew R Haynes; Mike Furlan; Robert Schmieder; Yan Wei Lim; Paul B Rainey; Forest Rohwer; Douglas Conrad
Journal:  ISME J       Date:  2011-07-28       Impact factor: 10.302

2.  Comparison of DNA extraction methods for microbial community profiling with an application to pediatric bronchoalveolar lavage samples.

Authors:  Dana Willner; Joshua Daly; David Whiley; Keith Grimwood; Claire E Wainwright; Philip Hugenholtz
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

3.  Bacterial distribution in the lungs of children with protracted bacterial bronchitis.

Authors:  Ravi Narang; Kelly Bakewell; Jane Peach; Sadie Clayton; Martin Samuels; John Alexander; Warren Lenney; Francis J Gilchrist
Journal:  PLoS One       Date:  2014-09-26       Impact factor: 3.240

4.  An observational study examining the relationship between respiratory symptoms, airway inflammation and bacteriology in children with severe neurodisability.

Authors:  Ruth E Trinick; Lara Bunni; Kent Thorburn; Angela P Hackett; Mark Dalzell; Paul S McNamara
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

5.  Ability of device to collect bacteria from cough aerosols generated by adults with cystic fibrosis.

Authors:  David N Ku; Sarah K Ku; Beth Helfman; Nael A McCarty; Bernard J Wolff; Jonas M Winchell; Larry J Anderson
Journal:  F1000Res       Date:  2016-08-05

6.  Successful outcome following pneumonectomy in a teenage boy with cystic fibrosis: a case report.

Authors:  Zheyi Liew; Santosh Mallikarjuna; Asif Hasan; F Kate Gould; Su Bunn; Matthew F Thomas; Jim L Lordan; Christopher O'Brien; Malcolm Brodlie
Journal:  BMC Pulm Med       Date:  2017-01-13       Impact factor: 3.317

Review 7.  Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.

Authors:  Kamini Jain; Claire Wainwright; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2018-09-17

8.  Microbiota present in cystic fibrosis lungs as revealed by whole genome sequencing.

Authors:  Philippe M Hauser; Thomas Bernard; Gilbert Greub; Katia Jaton; Marco Pagni; Gaudenz M Hafen
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

9.  Airway Microbiota in Bronchoalveolar Lavage Fluid from Clinically Well Infants with Cystic Fibrosis.

Authors:  Theresa A Laguna; Brandie D Wagner; Cynthia B Williams; Mark J Stevens; Charles E Robertson; Cole W Welchlin; Catherine E Moen; Edith T Zemanick; Jonathan K Harris
Journal:  PLoS One       Date:  2016-12-08       Impact factor: 3.240

Review 10.  An underestimated cause of chronic cough: The Protracted Bacterial Bronchitis.

Authors:  Paola Di Filippo; Alessandra Scaparrotta; Marianna Immacolata Petrosino; Marina Attanasi; Sabrina Di Pillo; Francesco Chiarelli; Angelika Mohn
Journal:  Ann Thorac Med       Date:  2018 Jan-Mar       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.